![]() ![]() The series, called “Clarion,” serves as “another testament to the space and what I really want to give to the artists,” Haynes said. She will also capitalize on David Zwirner’s growing publishing arm-an operation more commonly attached to blue-chip outfits nowadays-to work with each artist on an exhibition catalogue. The duration of exhibitions won’t be the only way in which Haynes works toward a less ephemeral model. Each show will last three months, a run more reminiscent of a kunsthalle than a commercial gallery, which traditionally cycles through shows every four to six weeks. For Haynes, who has worked with most of them before, that is a big part of the draw. They are, in order, L.A.-based sculptor and installation artist Nikita Gale Amsterdam-based performance artist Nora Turato Philadelphia-based conceptual artist Tiona Nekkia McClodden and Canadian assemblage artist Tau Lewis.ĭeeply considered and conceptual, each of these artists makes work that is difficult to categorize and nearly impossible to capture in an Instagram post. True to Haynes’s desire to, as she put it, “change the model and slow things down,” the first calendar year of programming, in 2022, will include only four additional solo shows. Installation image, “Kandis Williams: A Field” at the Institute for Contemporary Art at Virginia Commonwealth University, 2020. Fresh off her first institutional exhibition at the Institute for Contemporary Art at Virginia Commonwealth University, which was a deep dive into systems of exploitative labor, the 52 Walker show marks Williams’s solo debut in New York. The inaugural show is a solo presentation of work by the Los Angeles-based multidisciplinary artist Kandis Williams. That idea has now become reality in the form of 52 Walker, which opens in October and takes its name from its location to honor the artist-run spaces that were once signature in Tribeca. With her sights set on an even bigger shift, she took the opportunity to pitch Zwirner a fresh idea for an art space: a cross between a commercial gallery and a kunsthalle that would allow artists, visitors, and staff alike to slow down, experiment, and really consider challenging art.īefore long, what started as an offer to sign on to his team in a traditional role turned into “a much more ambitious idea,” David Zwirner said in a statement. Like so many people grappling with the pandemic-along with a growing social justice movement-she felt as though “the stake in the art world for me had changed a lot,” she told Artnet News.Īt the time, Haynes had already been approached by a few big-name galleries, including David Zwirner, about taking a sales director position. She’d spent years building her career as a dealer, most recently doing double duty as both director of contemporary art gallery Martos and its edgy offshoot project space, Shoot the Lobster. Haynes felt like it was time for a change. "I look forward to helping advance Ansa’s on-going transformation as we progress toward offering industry-leading products that will have a positive impact on society.Last summer, Ebony L. "I am deeply grateful and honored to have the opportunity to lead this creative and talented growing team of scientists and engineers," Hanes said. Hanes is an inventor on 32 US issued patents and has 28 peer-reviewed scientific publications. from The University of Texas-Austin and completed his postdoctoral research in Chemical Biology at Cornell University. degree in Biochemistry from The University of Nebraska-Lincoln, a Ph.D. During his more than 13-year tenure at PacBio, he and his teams contributed meaningfully to nearly every new product. Hanes joins Ansa from PacBio, a leading developer of highly accurate and comprehensive DNA sequencing technologies, where he was most recently Vice President of Reagents R&D. ![]() "His broad expertise and leadership abilities in guiding cross-disciplinary teams will be invaluable as we advance our ‘long-write’ synthesis technology that will power our fast and reliable DNA synthesis service."ĭr. "Jeremiah is a proven leader in the biotechnology industry who was instrumental in the development of ‘long-read’ sequencing technologies that have had a profound impact on genomics, diagnostics, and our understanding of the natural world," said Daniel Lin-Arlow, CEO & Co-Founder. He joins Ansa’s Senior Executive Team and will be responsible for the advancement of all research and development activities. EMERYVILLE, Calif., August 23, 2022-( BUSINESS WIRE)- Ansa Biotechnologies, today announced the appointment of Jeremiah Hanes, Ph.D., as Senior Vice President (SVP) of Research & Development (R&D).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |